e-learning
resources
Stockholm 2002
Sunday 15.09.2002
Thoracic oncology: biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth
in vivo
by retrovirus-mediated gene transfer
A. A. Mancini, V. V. Esposito, A. A. De Luca, P. P. P. P. Claudio, A. M. A. M. Groeger, A. A. Giordamo, M. M. Caputi (Naples, Italy; Philadelphia, United States Of America)
Source:
Annual Congress 2002 - Thoracic oncology: biology
Session:
Thoracic oncology: biology
Session type:
Oral Presentation
Number:
143
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. A. Mancini, V. V. Esposito, A. A. De Luca, P. P. P. P. Claudio, A. M. A. M. Groeger, A. A. Giordamo, M. M. Caputi (Naples, Italy; Philadelphia, United States Of America). Mutations in the retinoblastoma-related gene RB2/p130 in lung tumours and suppression of tumour growth
in vivo
by retrovirus-mediated gene transfer. Eur Respir J 2002; 20: Suppl. 38, 143
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Related content which might interest you:
Suppression of HIF-1a dependent gene regulation by the tumour suppressor gene PTEN in pulmonary cells
Source: Eur Respir J 2001; 18: Suppl. 33, 17s
Year: 2001
Inhibition of tumor growth and metastatic lung tumors in mice by adenovirus-mediated interferon-β gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 199s
Year: 2003
Adenovirus-mediated interferon-beta gene therapy inhibits tumor growth and inhibits metastatic lung tumors in mice
Source: Eur Respir J 2002; 20: Suppl. 38, 186s
Year: 2002
Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Is caveolin-1 lost as a tumor suppressor gene in lung carcinoma?
Source: Annual Congress 2004 - Lung development and cancer
Year: 2004
MDM2 gene amplification and mdm2 protein expression in NSCLC cells
Source: Eur Respir J 2005; 26: Suppl. 49, 91s
Year: 2005
T cell specific expression of a short splice variant of the tumor suppressor gene CYLD amplifies the development of allergic airway disease
Source: Annual Congress 2011 - T-cell subsets
Year: 2011
Adenovirus-mediated interferon-β gene therapy combined with radiotherapy synergistically inhibits lung tumor growth in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 79s
Year: 2004
Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis
Source: Eur Respir J 2002; 20: 703-709
Year: 2002
N-terminal deletion augments the cell death-inducing activity of BAX in the adenoviral gene delivery to nonsmall cell lung cancers
Source: Eur Respir J 2002; 20: Suppl. 38, 14s
Year: 2002
The correlation between p53 gene mutation and the expression of tumor drug resistance genes in lung cancer and its clinical significance
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005
EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Downregulation of expression growth factor receptor induced by vector-based siRNA and its effect on radiosensitivity of pulmonary adenocarcinoma cell line
Source: Eur Respir J 2006; 28: Suppl. 50, 810s
Year: 2006
p53 gene mutations in lung cancer in Korean
Source: Eur Respir J 2005; 26: Suppl. 49, 327s
Year: 2005
Hypoxia-induced methylation of the Thy-1 promoter is associated with transcriptional repression in human primary lung fibroblasts
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
The role of P53 tumor suppressor gene mutations in early diagnosis of lung cancer among patients with solitary pulmonary nodule
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009
ASCL1 suppress ZFP36L1 expression by regulating miR124-3p expression in lung adenocarcinoma
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011
Tumoural tissue specific promoter hypermethylation of distinct tumour suppressor genes in a case with nonsmall cell lung carcinoma: a case report
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept